Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News
  • Published:

Stemming kidney cancer

Nature (2000)Cite this article

Stem cell transplants are problematic but they can halt the progress of certain cancers, Helen Gavaghan reports.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Childs, R. et al. Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation. New England Journal of Medicine 343, 750 - 758 2000.

    Article  CAS  Google Scholar 

  2. Childs, R. et al. Successful treatment of metastatic renal-cell carcinoma with a nonmyeloablative allogeneic peripheral blood progenitor cell transplant: evidence for graft versus tumor effect. Journal of Clinical Oncology 17, 2044 1999.

    Article  CAS  Google Scholar 

Download references

Authors
  1. Helen Gavaghan
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gavaghan, H. Stemming kidney cancer. Nature (2000). https://doi.org/10.1038/news000928-4

Download citation

  • Published:

  • DOI: https://doi.org/10.1038/news000928-4

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing